Login / Signup

Tumor shrinkage patterns of nivolumab monotherapy in metastatic renal cell carcinoma.

Kosuke HamadaRyo FujiwaraKosuke TakemuraYoshinobu KomaiTomohiko OguchiNoboru NumaoShinya YamamotoJunji YoneseTakeshi Yuasa
Published in: International journal of urology : official journal of the Japanese Urological Association (2022)
Pretreatment tumor size was not associated with the tumor shrinkage rate and overall survival in nivolumab monotherapy.
Keyphrases
  • metastatic renal cell carcinoma
  • combination therapy